He is not wrong...
The Digital Rust Belt: Inside Ohio’s Billion-Dollar Data Center Speculation Wave
"Whether it’s 16 data centers or 6 data centers there’s always '200 jobs'. Why? It’s enough jobs to look beneficial but not too many to break your school system"
According to Utah State University physics professor Robert Davies, the proposed Stratos 9 gigawatt data center would generate 16 gigawatts of heat concentrated in one location. This is the equivalent of detonating 23 atomic bombs, and would easily raise the nighttime temperature by a staggering 28 degrees. Put simply, it would be an ecological disaster.
Full report: https://t.co/UOdOLYuGNA
DREAM TEAM INGREDIENTS for foot soak or bath. Use 1 cup each of powders for a bath and 1/4 cup h2o2
Happy parasite 🪱 HUNTING!!! 1/2 CUP BORAX 1/2 CUP SEA SALT 1/4 CUP BAKING SODA 3 TABLESPOONS HYDROGINE PEROXIDE SOME HOT ASS WATER 💧 20 TO 30 MINUTES
I have put together a remarkable global map of every data center under construction or planned for construction.
It shows a staggering 3,000 - 3,500 data centers being built or already announced to be built, consuming 190 GW of power when completed.
They will consume over 1,000 square km of land and 15+ billion liters of water per year, in all.
You are free to use this infographic in your videos and broadcasts. It's rendered at 4k. Just please give a call out to Natural News. The infographic is 99% correct but could have small typos or slight geographic variance, since it's AI-rendered.
Enjoy and share!
🚨 SHOCKING
Nattokinase DISSOLVES 84% of prion-like amyloid microclots in JUST 2 HOURS — in the lab! These abnormal clots were found in 100% of COVID-19 vaccinated individuals tested. Massive white fibrous clots pulled from 20-40% of deceased worldwide.
🚨DATA CENTERS: Kristen Meghan Joins War Room Live Discussing How Literally No One Voted For Data Centers. Now They Are Forcing People Out of Their Homes. “How Are They Ever Going To Sell Their Home?” FULL INTERVIEW
@KristenMeghan@HarrisonHSmith
🔴WATCH THE LIVESTREAM!👇
https://t.co/6edBuRQp7u
Nattokinase DISSOLVES 84% of amyloid microclots within 2 hours in-vitro — a pathology recently found in 100% of COVID-19 vaccinated individuals tested.
This natural enzyme helps break down BOTH the trigger (spike protein) AND the pathological result (amyloid microclots).
🔥 BREAKING MEDICAL ALERT: DR. WILLIAM MAKIS CANCER PROTOCOL — Ivermectin & Fenbendazole Dosing Shaking The Medical World — REAL CASES, REAL RESULTS
🔥 Explosive cancer protocol from Dr. William Makis is shaking the medical world as #Ivermectin and #Fenbendazole dosing, backed by real case outcomes, sparks massive attention and raises urgent questions about alternative treatment paths.
🔥 IVERMECTIN DOSAGE — FROM PREVENTION TO LAST-RESORT INTERVENTION
👉 FULL STORY: https://t.co/WNngtVyxyF
🔥 ALSO: DR. WILLIAM MAKIS: THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT — Ivermectin Cure, Fenbendazole Treatment, and the Truth They Buried [VIDEO] https://t.co/HUBAptolCv
📢 Join Telegram: https://t.co/FWCa4CamU4
🌐 Real stories. True journalism: https://t.co/F2U5vWBg3k
NEW ARTICLE: RESEARCH: NICLOSAMIDE in CANCER and other diseases - 2025 Review Paper from Henan, China
NICLOSAMIDE was approved by FDA in 1982 for treating tapeworm infections, and was designated an essential drug by WHO.
NICLOSAMIDE in CANCER Mechanisms:
1. Mitochondrial uncoupling - this is its major anti-cancer mechanism
Niclosamide acts like a mild “leak” in the mitochondrial membrane, letting protons slip across without making ATP. This increases oxygen use, lowers ATP levels, raises AMP/ATP ratio & activates AMPK (energy sensor) to inhibit mTOR (slows down cancer cell growth).
Cancer cells, which often rely on inefficient energy pathways (Warburg effect), are especially vulnerable.
This can lead to inhibition of ATP synthesis, exhausting cellular energy reserves, metabolic stress, and cell death.
2. Signal pathway modulation - It inhibits several “pro-cancer” pathways, including:
- Wnt/β-catenin (important in cancer proliferation, especially colorectal).
- mTOR (controls cell proliferation, growth and metabolism).
- Notch pathway (controls proliferation, growth, angiogenesis and cellular migration)
- STAT3, NF-κB, etc. (cancer survival, proliferation).
- Promotes apoptosis (programmed cell death) and reduce inflammation.
3. Combination with existing chemotherapies
4. Addresses Multi-Drug Resistance - by enhancing production of reactive oxygen species.
OTHER DISEASES - beyond cancer, Niclosamide’s versatility includes:
Anti-bacterial - strong in vitro activity against resistant gram-positive bacteria.
its antibacterial activity involves altering bacterial morphology, reducing intracellular ATP, and inhibiting α-HL secretion (Staph Aureus)
it inhibits all three toxins of Clostridium difficile by targeting a host process essential for toxin entry into colonocytes. In a mouse model, it reduced both primary disease and recurrence without affecting gut microbiota diversity
it demonstrates marked inhibition of vancomycin-resistant Enterococcus faecium (VRE)
It effectively eliminates H. pylori adhesion/invasion
Anti-Fungal - demonstrates impressive antifungal effects in vitro and in vivo niclosamide effectively disrupted and removed biofilms of drug-resistant Candida albicans and Candida auris by targeting mitochondrial respiration
Anti-Viral - Niclosamide could have action against SARS-CoV, MERS, Zika, Hepatitis C, Ebola, EBV
Niclosamide inhibits viral replication by reducing mTOR activation and prevents viral entry
inhibits virion production in EBV-infected cells while showing cytotoxicity and inducing cell cycle arrest
demonstrates strong activity against RSV in vitro, with a 94 % inhibition rate
suppresses Hepatitis C replication and reduces viral load
Metabolic disorders (e.g., Type II Diabetes, fatty liver): Mitochondrial effects and AMPK activation can improve energy balance and reduce fat accumulation.
Diabetes: modulates metabolic pathways, improves insulin sensitivity
Fatty liver (NASH, NAFLD) - reduces hepatic inflammation
Neuropathic Pain - reduces inflammation by inhibiting NF-kB, STAT3
alleviates pain and nerve damage
Rheumatoid Arthritis - inhibits NF-kB activation
reduces secretion of IL-6 and other inflammatory cytokines,
blocks migration and invasion of RA fibroblast-like synoviocytes.
Psoriasis - inhibits keratinocyte hyperproliferation and reduces inflammation by downregulation of STAT3, NF-kB.
Airway Diseases (Asthma, Cystic Fibrosis, COPD)
Niclosamide inhibits certain Ca-activated Cl channels involved in mucus hypersecretion & bronchoconstriction (reduces mucus production & secretion.
it blocks release of mucus and inflammatory mediators which reduces bronchoconstriction.
anti-fibrotic agent for lung fibrosis - Niclosamide downregulates expression of collagen proteins and inhibits pro-fibrotic cytokines.
Endometriosis - Niclosamide targets STAT3 and NF-kB, reduces proinflammatory cytokines and reduces endometriotic lesion growth.
ALS
In vivo experimentation involving two ALS mouse models demonstrated slowed disease progression, enhanced survival rates, and reduced motor neuron loss and muscle atrophy.
At the molecular level, niclosamide inhibited dysregulated pathways such as STAT3 and mTOR, reduced gliosis, and dampened inflammatory signaling
niclosamide has shown remarkable potential by efficiently inhibiting the expression of S100A4, a Ca2+-binding protein frequently upregulated in reactive microglia and astrocytes in ALS models. This inhibition contributes to reduced microglial reactivity, cytoskeletal changes & inflammation in ALS
Systemic Sclerosis - inhibits STAT3, AKT, and Wnt/β-catenin pathways
reduced immune cell activation
reversal of skin and lung fibrosis and reduced rate of inflammation
CONCLUSION:
Ivermectin, Mebendazole and Fenbendazole are leading the repurposed drug revolution
but Niclosamide is the most promising of the other anti-parasitics!
NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 54 year old California woman with Stage 4 NSCLC Lung Cancer 6.4x5.3cm with soft tissue metastases reports after 8 months: 93% lung mass tumor shrinkage!
STUNNING Ivermectin Cancer Testimonial! 😃
(please note that no one else posts Ivermectin Cancer success stories)
STORY:
54 year old California woman with Stage 4 NSCLC Lung Cancer with soft tissue metastases
In August 2025 she started:
Ivermectin, Fenbendazole, Tagrisso
Results after 8 months:
6.4x5.3cm Lung mass shrunk to 2.9x2.1cm = 93% Tumor Volume loss
Lung mass SUVmax 9.5 reduced to SUVmax 2.4 (resolved to background level)
Intrathoracic lymph node metastases up to 3.4cm = 100% resolved. All lymph node tumors are gone.
Soft tissue metastases = 100% resolved
For anyone who knows what Stage 4 NSCLC Lung Cancer metastatic to soft tissues is, this is a STUNNING RESULT!! 😃
The 6.4cm lung cancer mass shrunk to a metabolically inactive 2.9cm tumor that may be only a scar at this point...
and extensive lymph node and soft tissue metastases resolved completely.
When Lung cancer is metastatic to soft tissues, that's extremely advanced...
But adding repurposed drugs to conventional therapy like Tagrisso, can still reverse this very advanced disease!!
I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest Ivermectin Cancer Project in the world!!
We are moving this world-leading Ivermectin Cancer Project to FLORIDA!
Please be patient while we move, consultations are currently halted but the Clinic is coming soon!
God Bless...🙏
This is criminal. The communities ramming these in, the states allowing unfettered access and the EPA is responsible for allowing this to happen. You cannot hide from accountability.